Cargando…
A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence
The Eph kinases are the largest receptor tyrosine kinases (RTKs) family in humans. PC3 human prostate adenocarcinoma cells are a well-established model for studying Eph–ephrin pharmacology as they naturally express a high level of EphA2, a promising target for new cancer therapies. A pharmacological...
Autores principales: | Festuccia, Claudio, Corrado, Miriam, Rossetti, Alessandra, Castelli, Riccardo, Lodola, Alessio, Gravina, Giovanni Luca, Tognolini, Massimiliano, Giorgio, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609876/ https://www.ncbi.nlm.nih.gov/pubmed/37895923 http://dx.doi.org/10.3390/ph16101452 |
Ejemplares similares
-
UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling
por: Giorgio, Carmine, et al.
Publicado: (2021) -
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
por: Festuccia, Claudio, et al.
Publicado: (2018) -
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
por: Rusnati, Marco, et al.
Publicado: (2021) -
Correction: Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
por: Rusnati, Marco, et al.
Publicado: (2021) -
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase
Activation
por: Giorgio, Carmine, et al.
Publicado: (2011)